Whereas treatment-naive immediate responses in IBD include IL-2-propagated Tregs, resolving anti-inflammatory and tissue healing actions by IL-10 and IL-22 requires JAK/STAT signaling. Here, IL10 is linked to inflammatory bowel disease.